Role of plasmapheresis in neuromyelitis optica spectrum disorders

Purpose: We report a case of Neuromyelitis optica spectrum disorder (NMOSD) which has failed to respond to the first line treatment i.e. IV methylprednisolone and had responded well to the plasmapheresis. Method: A 23-year-old female presented with complaint of sudden painless diminution of visio...

Full description

Bibliographic Details
Main Authors: Pranathi B, Nashrah Nooreen, Madhuri Gadde, Anitha Videkar
Format: Article
Language:English
Published: KIMS Foundation and Research Center 2019-10-01
Series:Journal of Medical and Scientific Research
Subjects:
Online Access:http://jmsronline.com/article.aspx?ID=plasmapheresis-in-neuromyelitis-optica-spectrum-disorders
_version_ 1818541032998961152
author Pranathi B
Nashrah Nooreen
Madhuri Gadde
Anitha Videkar
author_facet Pranathi B
Nashrah Nooreen
Madhuri Gadde
Anitha Videkar
author_sort Pranathi B
collection DOAJ
description Purpose: We report a case of Neuromyelitis optica spectrum disorder (NMOSD) which has failed to respond to the first line treatment i.e. IV methylprednisolone and had responded well to the plasmapheresis. Method: A 23-year-old female presented with complaint of sudden painless diminution of vision in both eyes which is progressive in nature associated with severe headache, with no systemic symptoms, since 10 days. On examination patient denied perception to light in both eyes. On anterior segment examination both the pupil were 6mm dilated, ill sustained and sluggishly reacting to light, rest anterior segment was normal. Fundus examination of both eyes showed hyperemic pallid disc edema with blurring of margins all around associated with tortuous vessels with foveal reflux present. We started her on IV methyl prednisolone for 3 days but did not respond, then we switched to plasmapheresis. Results: After 2nd cycles of plasmapheresis the vision improved to hand movement in both eyes and after 7thcycle the vision improved to counting fingers at 4meters. And the patient was maintained on tapering dose of steroids (50mg/day) and azathioprine 100mg/day (2-3 mg/kg/day) was started. Conclusions: Plasmapheresis is an effective therapy in NMOSD patients and should be considered if the patient fails to respond to the initial therapy.
first_indexed 2024-12-11T22:03:14Z
format Article
id doaj.art-48d46af856bf42c3bb02d75824e93ba4
institution Directory Open Access Journal
issn 2321-1326
2394-112X
language English
last_indexed 2024-12-11T22:03:14Z
publishDate 2019-10-01
publisher KIMS Foundation and Research Center
record_format Article
series Journal of Medical and Scientific Research
spelling doaj.art-48d46af856bf42c3bb02d75824e93ba42022-12-22T00:49:02ZengKIMS Foundation and Research CenterJournal of Medical and Scientific Research2321-13262394-112X2019-10-017411511910.17727/JMSR.2019/7-20Role of plasmapheresis in neuromyelitis optica spectrum disordersPranathi B0Nashrah Nooreen1Madhuri Gadde2Anitha Videkar3Department of Ophthalmology, Krishna Institute of Medical Sciences (KIMS), Secunderabad-500003, Telangana, India Department of Ophthalmology, Krishna Institute of Medical Sciences (KIMS), Secunderabad-500003, Telangana, India Department of Ophthalmology, Krishna Institute of Medical Sciences (KIMS), Secunderabad-500003, Telangana, India Department of Ophthalmology, Krishna Institute of Medical Sciences (KIMS), Secunderabad-500003, Telangana, India Purpose: We report a case of Neuromyelitis optica spectrum disorder (NMOSD) which has failed to respond to the first line treatment i.e. IV methylprednisolone and had responded well to the plasmapheresis. Method: A 23-year-old female presented with complaint of sudden painless diminution of vision in both eyes which is progressive in nature associated with severe headache, with no systemic symptoms, since 10 days. On examination patient denied perception to light in both eyes. On anterior segment examination both the pupil were 6mm dilated, ill sustained and sluggishly reacting to light, rest anterior segment was normal. Fundus examination of both eyes showed hyperemic pallid disc edema with blurring of margins all around associated with tortuous vessels with foveal reflux present. We started her on IV methyl prednisolone for 3 days but did not respond, then we switched to plasmapheresis. Results: After 2nd cycles of plasmapheresis the vision improved to hand movement in both eyes and after 7thcycle the vision improved to counting fingers at 4meters. And the patient was maintained on tapering dose of steroids (50mg/day) and azathioprine 100mg/day (2-3 mg/kg/day) was started. Conclusions: Plasmapheresis is an effective therapy in NMOSD patients and should be considered if the patient fails to respond to the initial therapy.http://jmsronline.com/article.aspx?ID=plasmapheresis-in-neuromyelitis-optica-spectrum-disordersneuromyelitis opticapainless progressive diminision of visionsluggishly reacting pupilhyperemic pallid discmethylprednisoloneplasmapheresis
spellingShingle Pranathi B
Nashrah Nooreen
Madhuri Gadde
Anitha Videkar
Role of plasmapheresis in neuromyelitis optica spectrum disorders
Journal of Medical and Scientific Research
neuromyelitis optica
painless progressive diminision of vision
sluggishly reacting pupil
hyperemic pallid disc
methylprednisolone
plasmapheresis
title Role of plasmapheresis in neuromyelitis optica spectrum disorders
title_full Role of plasmapheresis in neuromyelitis optica spectrum disorders
title_fullStr Role of plasmapheresis in neuromyelitis optica spectrum disorders
title_full_unstemmed Role of plasmapheresis in neuromyelitis optica spectrum disorders
title_short Role of plasmapheresis in neuromyelitis optica spectrum disorders
title_sort role of plasmapheresis in neuromyelitis optica spectrum disorders
topic neuromyelitis optica
painless progressive diminision of vision
sluggishly reacting pupil
hyperemic pallid disc
methylprednisolone
plasmapheresis
url http://jmsronline.com/article.aspx?ID=plasmapheresis-in-neuromyelitis-optica-spectrum-disorders
work_keys_str_mv AT pranathib roleofplasmapheresisinneuromyelitisopticaspectrumdisorders
AT nashrahnooreen roleofplasmapheresisinneuromyelitisopticaspectrumdisorders
AT madhurigadde roleofplasmapheresisinneuromyelitisopticaspectrumdisorders
AT anithavidekar roleofplasmapheresisinneuromyelitisopticaspectrumdisorders